Table of Contents United States Bacterial Vaginosis Drug Market Report 2017 1 Bacterial Vaginosis Drug Overview 1.1 Product Overview and Scope of Bacterial Vaginosis Drug 1.2 Classification of Bacterial Vaginosis Drug by Product Category 1.2.1 United States Bacterial Vaginosis Drug Market Size (Sales Volume) Comparison by Type (2012-2022) 1.2.2 United States Bacterial Vaginosis Drug Market Size (Sales Volume) Market Share by Type (Product Category) in 2016 1.2.3 Rx 1.2.4 OTC 1.3 United States Bacterial Vaginosis Drug Market by Application/End Users 1.3.1 United States Bacterial Vaginosis Drug Market Size (Consumption) and Market Share Comparison by Application (2012-2022) 1.3.2 Hospital 1.3.3 Pharmacy 1.3.4 Other 1.4 United States Bacterial Vaginosis Drug Market by Region 1.4.1 United States Bacterial Vaginosis Drug Market Size (Value) Comparison by Region (2012-2022) 1.4.2 The West Bacterial Vaginosis Drug Status and Prospect (2012-2022) 1.4.3 Southwest Bacterial Vaginosis Drug Status and Prospect (2012-2022) 1.4.4 The Middle Atlantic Bacterial Vaginosis Drug Status and Prospect (2012-2022) 1.4.5 New England Bacterial Vaginosis Drug Status and Prospect (2012-2022) 1.4.6 The South Bacterial Vaginosis Drug Status and Prospect (2012-2022) 1.4.7 The Midwest Bacterial Vaginosis Drug Status and Prospect (2012-2022) 1.5 United States Market Size (Value and Volume) of Bacterial Vaginosis Drug (2012-2022) 1.5.1 United States Bacterial Vaginosis Drug Sales and Growth Rate (2012-2022) 1.5.2 United States Bacterial Vaginosis Drug Revenue and Growth Rate (2012-2022) 2 United States Bacterial Vaginosis Drug Market Competition by Players/Suppliers 2.1 United States Bacterial Vaginosis Drug Sales and Market Share of Key Players/Suppliers (2012-2017) 2.2 United States Bacterial Vaginosis Drug Revenue and Share by Players/Suppliers (2012-2017) 2.3 United States Bacterial Vaginosis Drug Average Price by Players/Suppliers (2012-2017) 2.4 United States Bacterial Vaginosis Drug Market Competitive Situation and Trends 2.4.1 United States Bacterial Vaginosis Drug Market Concentration Rate 2.4.2 United States Bacterial Vaginosis Drug Market Share of Top 3 and Top 5 Players/Suppliers 2.4.3 Mergers & Acquisitions, Expansion in United States Market 2.5 United States Players/Suppliers Bacterial Vaginosis Drug Manufacturing Base Distribution, Sales Area, Product Type 3 United States Bacterial Vaginosis Drug Sales (Volume) and Revenue (Value) by Region (2012-2017) 3.1 United States Bacterial Vaginosis Drug Sales and Market Share by Region (2012-2017) 3.2 United States Bacterial Vaginosis Drug Revenue and Market Share by Region (2012-2017) 3.3 United States Bacterial Vaginosis Drug Price by Region (2012-2017) 4 United States Bacterial Vaginosis Drug Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017) 4.1 United States Bacterial Vaginosis Drug Sales and Market Share by Type (Product Category) (2012-2017) 4.2 United States Bacterial Vaginosis Drug Revenue and Market Share by Type (2012-2017) 4.3 United States Bacterial Vaginosis Drug Price by Type (2012-2017) 4.4 United States Bacterial Vaginosis Drug Sales Growth Rate by Type (2012-2017) 5 United States Bacterial Vaginosis Drug Sales (Volume) by Application (2012-2017) 5.1 United States Bacterial Vaginosis Drug Sales and Market Share by Application (2012-2017) 5.2 United States Bacterial Vaginosis Drug Sales Growth Rate by Application (2012-2017) 5.3 Market Drivers and Opportunities 6 United States Bacterial Vaginosis Drug Players/Suppliers Profiles and Sales Data 6.1 Bayer 6.1.1 Company Basic Information, Manufacturing Base and Competitors 6.1.2 Bacterial Vaginosis Drug Product Category, Application and Specification 6.1.2.1 Product A 6.1.2.2 Product B 6.1.3 Bayer Bacterial Vaginosis Drug Sales, Revenue, Price and Gross Margin (2012-2017) 6.1.4 Main Business/Business Overview 6.2 Pfizer 6.2.2 Bacterial Vaginosis Drug Product Category, Application and Specification 6.2.2.1 Product A 6.2.2.2 Product B 6.2.3 Pfizer Bacterial Vaginosis Drug Sales, Revenue, Price and Gross Margin (2012-2017) 6.2.4 Main Business/Business Overview 6.3 Sanofi 6.3.2 Bacterial Vaginosis Drug Product Category, Application and Specification 6.3.2.1 Product A 6.3.2.2 Product B 6.3.3 Sanofi Bacterial Vaginosis Drug Sales, Revenue, Price and Gross Margin (2012-2017) 6.3.4 Main Business/Business Overview 6.4 Piramal 6.4.2 Bacterial Vaginosis Drug Product Category, Application and Specification 6.4.2.1 Product A 6.4.2.2 Product B 6.4.3 Piramal Bacterial Vaginosis Drug Sales, Revenue, Price and Gross Margin (2012-2017) 6.4.4 Main Business/Business Overview 6.5 Abbott 6.5.2 Bacterial Vaginosis Drug Product Category, Application and Specification 6.5.2.1 Product A 6.5.2.2 Product B 6.5.3 Abbott Bacterial Vaginosis Drug Sales, Revenue, Price and Gross Margin (2012-2017) 6.5.4 Main Business/Business Overview 6.6 Galderma 6.6.2 Bacterial Vaginosis Drug Product Category, Application and Specification 6.6.2.1 Product A 6.6.2.2 Product B 6.6.3 Galderma Bacterial Vaginosis Drug Sales, Revenue, Price and Gross Margin (2012-2017) 6.6.4 Main Business/Business Overview 6.7 Mission 6.7.2 Bacterial Vaginosis Drug Product Category, Application and Specification 6.7.2.1 Product A 6.7.2.2 Product B 6.7.3 Mission Bacterial Vaginosis Drug Sales, Revenue, Price and Gross Margin (2012-2017) 6.7.4 Main Business/Business Overview 6.8 Alkem 6.8.2 Bacterial Vaginosis Drug Product Category, Application and Specification 6.8.2.1 Product A 6.8.2.2 Product B 6.8.3 Alkem Bacterial Vaginosis Drug Sales, Revenue, Price and Gross Margin (2012-2017) 6.8.4 Main Business/Business Overview 6.9 Xiuzheng 6.9.2 Bacterial Vaginosis Drug Product Category, Application and Specification 6.9.2.1 Product A 6.9.2.2 Product B 6.9.3 Xiuzheng Bacterial Vaginosis Drug Sales, Revenue, Price and Gross Margin (2012-2017) 6.9.4 Main Business/Business Overview 6.10 Teva 6.10.2 Bacterial Vaginosis Drug Product Category, Application and Specification 6.10.2.1 Product A 6.10.2.2 Product B 6.10.3 Teva Bacterial Vaginosis Drug Sales, Revenue, Price and Gross Margin (2012-2017) 6.10.4 Main Business/Business Overview 6.11 Perrigo 6.12 West-Ward 6.13 HPGC 6.14 Yunnan Baiyao 6.15 Starpharma 6.16 Novel 6.17 Edenvridge 7 Bacterial Vaginosis Drug Manufacturing Cost Analysis 7.1 Bacterial Vaginosis Drug Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Price Trend of Key Raw Materials 7.1.3 Key Suppliers of Raw Materials 7.1.4 Market Concentration Rate of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.2.1 Raw Materials 7.2.2 Labor Cost 7.2.3 Manufacturing Expenses 7.3 Manufacturing Process Analysis of Bacterial Vaginosis Drug 8 Industrial Chain, Sourcing Strategy and Downstream Buyers 8.1 Bacterial Vaginosis Drug Industrial Chain Analysis 8.2 Upstream Raw Materials Sourcing 8.3 Raw Materials Sources of Bacterial Vaginosis Drug Major Manufacturers in 2016 8.4 Downstream Buyers 9 Marketing Strategy Analysis, Distributors/Traders 9.1 Marketing Channel 9.1.1 Direct Marketing 9.1.2 Indirect Marketing 9.1.3 Marketing Channel Development Trend 9.2 Market Positioning 9.2.1 Pricing Strategy 9.2.2 Brand Strategy 9.2.3 Target Client 9.3 Distributors/Traders List 10 Market Effect Factors Analysis 10.1 Technology Progress/Risk 10.1.1 Substitutes Threat 10.1.2 Technology Progress in Related Industry 10.2 Consumer Needs/Customer Preference Change 10.3 Economic/Political Environmental Change 11 United States Bacterial Vaginosis Drug Market Size (Value and Volume) Forecast (2017-2022) 11.1 United States Bacterial Vaginosis Drug Sales Volume, Revenue Forecast (2017-2022) 11.2 United States Bacterial Vaginosis Drug Sales Volume Forecast by Type (2017-2022) 11.3 United States Bacterial Vaginosis Drug Sales Volume Forecast by Application (2017-2022) 11.4 United States Bacterial Vaginosis Drug Sales Volume Forecast by Region (2017-2022) 12 Research Findings and Conclusion 13 Appendix 13.1 Methodology/Research Approach 13.1.1 Research Programs/Design 13.1.2 Market Size Estimation 13.1.3 Market Breakdown and Data Triangulation 13.2 Data Source 13.2.1 Secondary Sources 13.2.2 Primary Sources 13.3 Disclaimer

List of Tables and Figures Figure Product Picture of Bacterial Vaginosis Drug Figure United States Bacterial Vaginosis Drug Market Size (K Pcs) by Type (2012-2022) Figure United States Bacterial Vaginosis Drug Sales Volume Market Share by Type (Product Category) in 2016 Figure Rx Product Picture Figure OTC Product Picture Figure United States Bacterial Vaginosis Drug Market Size (K Pcs) by Application (2012-2022) Figure United States Sales Market Share of Bacterial Vaginosis Drug by Application in 2016 Figure Hospital Examples Table Key Downstream Customer in Hospital Figure Pharmacy Examples Table Key Downstream Customer in Pharmacy Figure Other Examples Table Key Downstream Customer in Other Figure United States Bacterial Vaginosis Drug Market Size (Million USD) by Region (2012-2022) Figure The West Bacterial Vaginosis Drug Revenue (Million USD) and Growth Rate (2012-2022) Figure Southwest Bacterial Vaginosis Drug Revenue (Million USD) and Growth Rate (2012-2022) Figure The Middle Atlantic Bacterial Vaginosis Drug Revenue (Million USD) and Growth Rate (2012-2022) Figure New England Bacterial Vaginosis Drug Revenue (Million USD) and Growth Rate (2012-2022) Figure The South of US Bacterial Vaginosis Drug Revenue (Million USD) and Growth Rate (2012-2022) Figure The Midwest Bacterial Vaginosis Drug Revenue (Million USD) and Growth Rate (2012-2022) Figure United States Bacterial Vaginosis Drug Sales (K Pcs) and Growth Rate (2012-2022) Figure United States Bacterial Vaginosis Drug Revenue (Million USD) and Growth Rate (2012-2022) Figure United States Bacterial Vaginosis Drug Market Major Players Product Sales Volume (K Pcs) (2012-2017) Table United States Bacterial Vaginosis Drug Sales (K Pcs) of Key Players/Suppliers (2012-2017) Table United States Bacterial Vaginosis Drug Sales Share by Players/Suppliers (2012-2017) Figure 2016 United States Bacterial Vaginosis Drug Sales Share by Players/Suppliers Figure 2017 United States Bacterial Vaginosis Drug Sales Share by Players/Suppliers Figure United States Bacterial Vaginosis Drug Market Major Players Product Revenue (Million USD) (2012-2017) Table United States Bacterial Vaginosis Drug Revenue (Million USD) by Players/Suppliers (2012-2017) Table United States Bacterial Vaginosis Drug Revenue Share by Players/Suppliers (2012-2017) Figure 2016 United States Bacterial Vaginosis Drug Revenue Share by Players/Suppliers Figure 2017 United States Bacterial Vaginosis Drug Revenue Share by Players/Suppliers Table United States Market Bacterial Vaginosis Drug Average Price (USD/Pcs) of Key Players/Suppliers (2012-2017) Figure United States Market Bacterial Vaginosis Drug Average Price (USD/Pcs) of Key Players/Suppliers in 2016 Figure United States Bacterial Vaginosis Drug Market Share of Top 3 Players/Suppliers Figure United States Bacterial Vaginosis Drug Market Share of Top 5 Players/Suppliers Table United States Players/Suppliers Bacterial Vaginosis Drug Manufacturing Base Distribution and Sales Area Table United States Players/Suppliers Bacterial Vaginosis Drug Product Category Table United States Bacterial Vaginosis Drug Sales (K Pcs) by Region (2012-2017) Table United States Bacterial Vaginosis Drug Sales Share by Region (2012-2017) Figure United States Bacterial Vaginosis Drug Sales Share by Region (2012-2017) Figure United States Bacterial Vaginosis Drug Sales Market Share by Region in 2016 Table United States Bacterial Vaginosis Drug Revenue (Million USD) and Market Share by Region (2012-2017) Table United States Bacterial Vaginosis Drug Revenue Share by Region (2012-2017) Figure United States Bacterial Vaginosis Drug Revenue Market Share by Region (2012-2017) Figure United States Bacterial Vaginosis Drug Revenue Market Share by Region in 2016 Table United States Bacterial Vaginosis Drug Price (USD/Pcs) by Region (2012-2017) Table United States Bacterial Vaginosis Drug Sales (K Pcs) by Type (2012-2017) Table United States Bacterial Vaginosis Drug Sales Share by Type (2012-2017) Figure United States Bacterial Vaginosis Drug Sales Share by Type (2012-2017) Figure United States Bacterial Vaginosis Drug Sales Market Share by Type in 2016 Table United States Bacterial Vaginosis Drug Revenue (Million USD) and Market Share by Type (2012-2017) Table United States Bacterial Vaginosis Drug Revenue Share by Type (2012-2017) Figure Revenue Market Share of Bacterial Vaginosis Drug by Type (2012-2017) Figure Revenue Market Share of Bacterial Vaginosis Drug by Type in 2016 Table United States Bacterial Vaginosis Drug Price (USD/Pcs) by Types (2012-2017) Figure United States Bacterial Vaginosis Drug Sales Growth Rate by Type (2012-2017) Table United States Bacterial Vaginosis Drug Sales (K Pcs) by Application (2012-2017) Table United States Bacterial Vaginosis Drug Sales Market Share by Application (2012-2017) Figure United States Bacterial Vaginosis Drug Sales Market Share by Application (2012-2017) Figure United States Bacterial Vaginosis Drug Sales Market Share by Application in 2016 Table United States Bacterial Vaginosis Drug Sales Growth Rate by Application (2012-2017) Figure United States Bacterial Vaginosis Drug Sales Growth Rate by Application (2012-2017) Table Bayer Basic Information List Table Bayer Bacterial Vaginosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017) Figure Bayer Bacterial Vaginosis Drug Sales Growth Rate (2012-2017) Figure Bayer Bacterial Vaginosis Drug Sales Market Share in United States (2012-2017) Figure Bayer Bacterial Vaginosis Drug Revenue Market Share in United States (2012-2017) Table Pfizer Basic Information List Table Pfizer Bacterial Vaginosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017) Figure Pfizer Bacterial Vaginosis Drug Sales Growth Rate (2012-2017) Figure Pfizer Bacterial Vaginosis Drug Sales Market Share in United States (2012-2017) Figure Pfizer Bacterial Vaginosis Drug Revenue Market Share in United States (2012-2017) Table Sanofi Basic Information List Table Sanofi Bacterial Vaginosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017) Figure Sanofi Bacterial Vaginosis Drug Sales Growth Rate (2012-2017) Figure Sanofi Bacterial Vaginosis Drug Sales Market Share in United States (2012-2017) Figure Sanofi Bacterial Vaginosis Drug Revenue Market Share in United States (2012-2017) Table Piramal Basic Information List Table Piramal Bacterial Vaginosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017) Figure Piramal Bacterial Vaginosis Drug Sales Growth Rate (2012-2017) Figure Piramal Bacterial Vaginosis Drug Sales Market Share in United States (2012-2017) Figure Piramal Bacterial Vaginosis Drug Revenue Market Share in United States (2012-2017) Table Abbott Basic Information List Table Abbott Bacterial Vaginosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017) Figure Abbott Bacterial Vaginosis Drug Sales Growth Rate (2012-2017) Figure Abbott Bacterial Vaginosis Drug Sales Market Share in United States (2012-2017) Figure Abbott Bacterial Vaginosis Drug Revenue Market Share in United States (2012-2017) Table Galderma Basic Information List Table Galderma Bacterial Vaginosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017) Figure Galderma Bacterial Vaginosis Drug Sales Growth Rate (2012-2017) Figure Galderma Bacterial Vaginosis Drug Sales Market Share in United States (2012-2017) Figure Galderma Bacterial Vaginosis Drug Revenue Market Share in United States (2012-2017) Table Mission Basic Information List Table Mission Bacterial Vaginosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017) Figure Mission Bacterial Vaginosis Drug Sales Growth Rate (2012-2017) Figure Mission Bacterial Vaginosis Drug Sales Market Share in United States (2012-2017) Figure Mission Bacterial Vaginosis Drug Revenue Market Share in United States (2012-2017) Table Alkem Basic Information List Table Alkem Bacterial Vaginosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017) Figure Alkem Bacterial Vaginosis Drug Sales Growth Rate (2012-2017) Figure Alkem Bacterial Vaginosis Drug Sales Market Share in United States (2012-2017) Figure Alkem Bacterial Vaginosis Drug Revenue Market Share in United States (2012-2017) Table Xiuzheng Basic Information List Table Xiuzheng Bacterial Vaginosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017) Figure Xiuzheng Bacterial Vaginosis Drug Sales Growth Rate (2012-2017) Figure Xiuzheng Bacterial Vaginosis Drug Sales Market Share in United States (2012-2017) Figure Xiuzheng Bacterial Vaginosis Drug Revenue Market Share in United States (2012-2017) Table Teva Basic Information List Table Teva Bacterial Vaginosis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017) Figure Teva Bacterial Vaginosis Drug Sales Growth Rate (2012-2017) Figure Teva Bacterial Vaginosis Drug Sales Market Share in United States (2012-2017) Figure Teva Bacterial Vaginosis Drug Revenue Market Share in United States (2012-2017) Table Perrigo Basic Information List Table West-Ward Basic Information List Table HPGC Basic Information List Table Yunnan Baiyao Basic Information List Table Starpharma Basic Information List Table Novel Basic Information List Table Edenvridge Basic Information List Table Production Base and Market Concentration Rate of Raw Material Figure Price Trend of Key Raw Materials Table Key Suppliers of Raw Materials Figure Manufacturing Cost Structure of Bacterial Vaginosis Drug Figure Manufacturing Process Analysis of Bacterial Vaginosis Drug Figure Bacterial Vaginosis Drug Industrial Chain Analysis Table Raw Materials Sources of Bacterial Vaginosis Drug Major Players/Suppliers in 2016 Table Major Buyers of Bacterial Vaginosis Drug Table Distributors/Traders List Figure United States Bacterial Vaginosis Drug Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022) Figure United States Bacterial Vaginosis Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022) Figure United States Bacterial Vaginosis Drug Price (USD/Pcs) Trend Forecast (2017-2022) Table United States Bacterial Vaginosis Drug Sales Volume (K Pcs) Forecast by Type (2017-2022) Figure United States Bacterial Vaginosis Drug Sales Volume (K Pcs) Forecast by Type (2017-2022) Figure United States Bacterial Vaginosis Drug Sales Volume (K Pcs) Forecast by Type in 2022 Table United States Bacterial Vaginosis Drug Sales Volume (K Pcs) Forecast by Application (2017-2022) Figure United States Bacterial Vaginosis Drug Sales Volume (K Pcs) Forecast by Application (2017-2022) Figure United States Bacterial Vaginosis Drug Sales Volume (K Pcs) Forecast by Application in 2022 Table United States Bacterial Vaginosis Drug Sales Volume (K Pcs) Forecast by Region (2017-2022) Table United States Bacterial Vaginosis Drug Sales Volume Share Forecast by Region (2017-2022) Figure United States Bacterial Vaginosis Drug Sales Volume Share Forecast by Region (2017-2022) Figure United States Bacterial Vaginosis Drug Sales Volume Share Forecast by Region in 2022 Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources